MAINTAIN (Mucosal AblatIoN Therapy After INcretins)
Part of paid clinical trials in Cary, North Carolina.
- Sponsor
- Dr. Christopher McGowan
- Study ID
- NCT06734312
- Status
- Recruiting
Conditions
- Ablation Techniques
- GLP-1
- Obesity Prevention
- Obesity Recidivism
- Obesity and Obesity-related Medical Conditions
- Obesity and Overweight
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Gastric Fundal Mucosal Ablation (GFMA) — DEVICEEndoscopic Gastric Fundal Mucosal Ablation (GFMA) after discontinuation of GLP-1 therapy
Study Details
The purpose of this study is to assess the effect of gastric fundal mucosal ablation (GFMA) on weight trajectory following discontinuation of once-weekly semaglutide or tirzepatide in adults with obesity. In this study, GFMA will be performed on patients who have experienced \> 10% weight loss with GLP-1 therapy and who plan to discontinue use of GLP-1 medications for the duration of the study.
Key Dates
- Start date
- Jan 1, 2025
- Status verified
- Jan 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Gastric Fundal Mucosal Ablation (GFMA) following discontinuation of GLP-1 therapySubjects will undergo endoscopic Gastric Fundal Mucosal Ablation (GFMA) following following discontinuation of GLP-1 therapy. This will be performed by an experienced endoscopist specialized in bariatric endoscopy in a single endoscopic session.
Primary Outcome Measure
Percent Change in Total Body Weight Loss (TBWL) from Baseline [ Time Frame: 12 months ]
Central Contacts
- Shannon Casey, MS(919) 391-7843
- Chase Wooley, BS(984) 345-2988
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| True You Weight Loss | Cary | North Carolina | 27513 | Christopher McGowan, MD, MSCR (PRINCIPAL_INVESTIGATOR) |
| True You Weight Loss | Cary | North Carolina | 27513 | Christopher McGowan, MD, MSCR (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Cary, NC
By research site
Related Studies
- A Mobile Intervention to Reduce Pain and Improve Health-IIIPHASE2 · Recruiting · Wake Forest University · Winston-Salem, North Carolina
- REvision of VSG with Ablation of the Mucosa ProcedureRecruiting · Dr. Christopher McGowan · Cary, North Carolina
- FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)Recruiting · University of North Carolina, Chapel Hill · Chapel Hill, North Carolina
- Efficacy and Safety of MET097 Once-Weekly in People With Overweight or ObesityPHASE3 · Recruiting · Pfizer · Scottsdale, Arizona